WG6. Clinical Trials
Leadership
Philippe Aftimos
INSTITUT BORDET
Elinor Sawyer
KING'S COLLEGE LONDON
Rachel Jankowitz
UNIVERSITY OF PENNSYLVANIA
Rian Terveer-Couperus
PA (NETHERLANDS)
Esther Geven
PA (NETHERLANDS)
Participants
| Alicia | Okines | Royal Marsden Hospital |
| Anya | Nicholas | Institute of Cancer Research |
| Caroline | Malhaire | Institut Curie |
| Chiara | Dauccia | Institut Jules Bordet |
| Christine | Desmedt | KU Leuven |
| Elisa | Agostinetto | Institut Jules Bordet |
| Esther | Geven | ELBCAdvocates |
| Karen | Van Baelen | KU Leuven |
| Meritxell | Bellet | Vall d Hebron University Hospital and VHIO |
| Patrick | Derksen | UMC Utrecht |
| Philippe | Aftimos | Institut Jules Bordet |
| Rachel | Jankowitz | University of Pennsylvania |
| Rachael | Natrajan | Institute of Cancer Research |
| Renee | Flaherty | Institute of Cancer Research |
| Rian | Terveer-Couperus | ELBCAdvocates |
| Sonia | Pernas | Catalan Institute of Oncology |
| Syed | Haider | Institute of Cancer Research |
| Thurkaa | Shanmugalingam | King’s College London |
| William | Yang | ICR |
| Yanbo | Liu | Institute of cancer research |
Past and Future meetings
GLOBAL STRATEGY MEETING (APRIL 16th 2024) LONDON)
Meeting at Guy’s Hospital in London. Hosted by Elly Sawyer. Discussions on ILC specific intervention options
LOBULAR BASKET TRIAL MEETING (OCTOBER 14th 2022) LONDON)
First clinical WG meeting at Guy’s Hospital in London. Hosted by Elly Sawyer. Discussions on ILC specific intervention options
Activities
The Clinical working group has been meeting on a regular basis and has played an important role in the start of the first ILC specific trials such as RoLo, ROSALINE, and the current developments in the context of AKT inhibition using Capivasertib.
A very comprehensive overview of the recent and ongoing ILC trials was published in 2024 by groups of the ELBCC headed by KU Leuven:
